Unituxin Antibody Therapy

Unituxin is a monoclonal antibody that targets the GD2 antigen present on neuroblastoma cells.
Unituxin is one of the therapies used to treat children with high-risk neuroblastoma, a cancer that arises from immature nerve cells.


We developed the 3D style for “How Unituxin Works” — a video for parents and caregivers, designed in collaboration with the agency Dagr Nott & Associates.


Link to the animation and Unituxin website:

www.unituxin.com/caregiver/understanding-unituxin/video

Neuroblastoma tumor cell and GD2 antigens – Style development

Antibody – Style development

Immune cells and Neuroblastoma cells – Style development

Threatening cell – Targeted by the immune system

Antibody and GD2 Antigen interaction

Neuron and GD2 Antigen – Style development

GET IN TOUCH

Please fill out this brief form to start the conversation or email us: hello@newtstudios.com

Let’s create the extraordinary together.

Your name*
Title*
Email*
Company*
Message*